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Structural studies of proteins normally require large quantities of pure material that can only be obtained
through heterologous expression systems and recombinant technique. In these procedures, large amounts
of expressed protein are often found in the insoluble fraction, making protein purification from the
soluble fraction inefficient, laborious, and costly. Usually, protein refolding is avoided due to a lack of
experimental assays that can validate correct folding and that can compare the conformational population to
that of the soluble fraction. Herein, we propose a validation method using simple and rapid 1D 1H nuclear
magnetic resonance (NMR) spectra that can efficiently compare protein samples, including individual
information of the environment of each proton in the structure.
H
eterologous expression of proteins in Escherichia coli is the most widespread technique used to produce
large amounts of protein for structural studies. However, a sufficient quantity of protein is not always
obtained using common, native, non-denaturant protocols. Major problems associated with rapid and
high-level expression in bacteria include protein aggregation and formation of inclusion bodies1. In some
structural genomics projects2,3, approximately 40% of the expressed targets are found in the insoluble fraction.
Although these proteins are usually discarded as viable targets, the use of a simple refolding protocol could resolve
the problem. Often, the fraction of soluble protein is not sufficient to make the production of large amounts of
protein viable, and, in these cases, use of a refolding protocol can be the best solution to increase protein yield.
Several techniques have been applied to refold proteins4–6, but the problem of how to solubilize and correctly fold
proteins remains a major issue. One of the main difficulties in using refolded proteins is that there are very few
experiments that discriminate between different conformational states and guarantee the correct refolding of the
protein. Enzymatic7–10 and biological activity11–13 have been widely used to confirm correct protein refolding.
However, in general, significant statistical error is associated with these assays, and the structural integrity of the
refolded sample cannot be ensured.With respect to direct analysis of protein structure, circular dichroism (CD) is
an effective technique only when large changes in secondary structure are present.
High resolution structural studies can be hindered by low yields of expressed protein or lack of an optimized
production/purification protocol. For example, obtaining a 3D nuclearmagnetic resonance (NMR) spectrum of a
20 kDa protein typically requires 5–10 mg of very pure and high cost isotopically-labeled protein. In x-ray
crystallography, large amounts of very concentrated protein are required to test crystallization conditions. In
addition, protein purity alone is not always sufficient to ensure successful crystal growth. Even small changes in a
protein’s three-dimensional structure can disturb crystal formation14–16. If an alternative conformation or oli-
gomer attaches to the crystal, it may form a crystal surface that prevents attachment of other protein molecules,
poisoning its growth17,18. Proteins can exist as multiple conformations in equilibrium due tomany factors, such as
structural flexibility, enzymatic activity, cooperativity, and oligomerization. For some experiments, conforma-
tional purity may not be important. For example, a biological activity assay of a protein with 20% in an inactive
conformation is equivalent to another experiment with 20% less protein, but with 100% in an active conforma-
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tion. However, in crystallography, NMR, and many other types of
studies, this information may be relevant and necessary. A simple
technique that can compare and ensure that different protein sam-
ples, obtained from different purification protocols, have the same
conformational distribution is helpful in such cases.
In this paper, we suggest the use of a simple and fast 1D 1H NMR
spectrum to validate refolding protocols before increasing protein
production. This technique is able to detect very small conforma-
tional changes in protein structure, as 1HNMR is sensitive to changes
in the environment of each hydrogen atom of a molecule (see e.g.19).
It represents a powerful method for the verification of the spatial
structure of (macro)molecules20 and gives us the expected informa-
tion, and these properties are unique and essential for subsequent
structural studies of the analyzed sample.
We applied the proposedmethod to P21 from Trypanosoma cruzi,
an 18 KDa protein that contains six cysteine residues that are all
expected to formdisulfide bonds. P21 is a ubiquitous secreted protein
of T. cruzi, the causative parasite of Chagas disease. P21 was found to
serve as part of host cell invasion mechanism21, triggering actin poly-
merization on the host cell via interactions with the CXCR4 chemo-
kine receptor22, which is present on the cellular membrane. Previous
studies21 showed that recombinant P21 (P21-His6, with an N-
terminal histidine tag) adheres to HeLa cells in a dose-dependent
manner. Additionally, invasion of HeLa cells by T. cruzi metacyclic
trypomastigotes (tissue cultured trypomastigotes, TCT) and extra-
cellular amastigotes (EA) is greatly increased in the presence of
P21-His6. Furthermore, P21-His6 upregulates the phagocytosis of
zymosan particles in mice peritoneal macrophages22, indicating that
P21 is involved in the phagocytic mechanism. More than 95% of
expressed P21-His6 is insoluble in Escherichia coli, making the yield
of the soluble protein insufficient for biological and structural stud-
ies. To overcome this limitation, we extracted P21-His6 from inclu-
sion bodies using urea and refolded it. Since recombinant P21 is
fused to a histidine tag, we used nickel affinity chromatography to
refold the protein by applying a slow urea gradient. This technique
has been used successfully to refold proteins in many cases23–27
because protein absorption on the solid matrix prevents aggregation
during the process through separation of individual protein mole-
cules5. To assess the available refolding validation techniques, we
compared parasite invasion and phagocytosis of particles induced
by refolded (rP21-His6) and soluble (sP21-His6) protein. As a second
approach, refolded and soluble protein structures were compared by
circular dichroism (CD) to find information regarding the state of
the proteins’ secondary structures. Finally, 1D 1HNMR spectra of the
soluble and refolded proteins were compared in order to confirm the
correct refolding of P21-His6 at atomic resolution. Comparison of
conformational identity between the soluble and refolded prepara-
tions is an essential analysis needed to perform structural studies
using the refolded material, and NMR spectroscopy is the only one
of these methods that addresses that question.
Results
The yield of P21-His6 was greatly improved when the protein was
recovered from inclusion bodies and refolded. In order to compare
the yield of soluble to refolded protein, we expressed recombinant
P21-His6 in 8 L 2xYT medium. Expression produced 24.9 g of dry
weight bacteria and 8.1 g of insoluble pellet after lysis and centrifu-
gation. Most of the protein was present in the insoluble fraction.
sP21-His6 was purified from the soluble fraction in a single step of
Nickel affinity chromatography; however, only 0.68 mg of purified
protein was obtained. The refolding procedure recovered 57.76 mg
of rP21-His6 from inclusion bodies, a yield 85 times greater than
purification from the soluble fraction.
Results from invasion and phagocytosis experiments demon-
strated that soluble and refolded P21-His6 have similar biological
properties. In the presence of sP21-His6, invasion of Vero cells by
TCT (Figure 1A) was increased approximately 3.6-fold, and invasion
by EA (Figure 1B) was increased approximately 2.4-fold. Similar
results were obtained for rP21-His6 (4.4-fold increase for TCT and
2.3-fold increase for EA). The difference between sP21-His6 and
rP21-His6 was not significant. Phagocytosis of zymosan particles
by macrophages was increased 3.5-fold with the addition of 40 mg/
mL sP21-His6 (Figure 1C) and 3.5-fold with the addition of 40 mg/
mL rP21-His622. The similarity of these increases suggests that
refolded and soluble protein exhibit the same biological properties.
Finally, CD and NMR experiments validated the correct refolding
of P21-His6. The CD spectra showed equivalent secondary structure
composition for both preparations (Figure 2B). Comparison between
1H NMR spectra of sP21-His6 and rP21-His6 showed exactly the
same chemical shifts and intensities for every proton in the structure
(Figure 2C). In this way, both samples could be compared directly
and were found to be identical to one another, with respect to both
correct folding and conformational ensemble. To better evaluate the
similarities (or differences) between the spectra of both samples, a
difference spectrum was calculated and is shown in Figure 2C (green
line). The larger differences can be assigned to non-protein compo-
nents of the sample (residual ethanol from concentrator rinsing,
small differences in DSS concentration, low molecular weight con-
taminants). These differences underscore the sensitivity of the
method and the identity of both protein conformations and ensem-
bles. In addition, up field shifts around 0 ppm in both spectra indi-
cate a hydrophobic nucleus in P21-His6, showing that the structure is
folded.
Discussion
In this study, we applied a one-step refolding procedure to P21-His6,
which increased the yield of the protein 85-fold. This refolding
method is based on immobilization of the P21-His6 on Nickel-affin-
ity resin, preventing protein aggregation during the process.
Refolding requires approximately 14 hours (which can be performed
overnight with no need for human interference) and uses less than
0.5 L of buffer. It is less laborious and quicker than other refolding
techniques, such as dialysis.
We used pre-existing biological information about P21 to develop
protein-specific assays that could be applied to both refolded and
soluble P21-His6 fractions. Both samples increased parasite invasion
and phagocytosis of zymosan particles at similar rates, suggesting
that they behaved identically with respect to biological activity. This
information would be sufficient in a majority of biological studies,
but is not sufficient for structural studies, in which correct folding
and conformational homogeneity of samples are essential.
As more structure-focused approaches, CD and NMR spectra
provided structural comparisons between sP21-His6 and rP21-
His6. Although CD measurements provide information about pro-
tein secondary structure, no information at an atomic resolution can
be provided. This method is more useful for identifying incorrectly
folded proteins by detecting differences in the spectra, because even if
two spectra are identical, we cannot confirm that structures are equal.
Simple one-dimensional 1H NMR overcomes this limitation by pro-
viding information about the environment of each 1H atom of the
protein, allowing a comparison of samples obtained by different
purification methods at atomic resolution. With this simple 1D 1H
NMR measurement, we confirmed that sP21-His6 and rP21-His6
have exactly the same structures and identical conformational equi-
libria. In addition, more important information can be obtained
from the spectrum: the good dispersion of the peaks over the ppm
scale indicates the presence of secondary structure, and the existence
of high-field shifted peaks around the reference (DSS at 0 ppm)
indicates the presence of a hydrophobic core in the protein.
Therefore, the structural and the biological data were in agreement,
as expected.
www.nature.com/scientificreports
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We propose the use of simple and fast 1D 1H NMR spectra to
validate refolding protocols before increasing protein production.
This technique is able to detect very small conformational changes
in protein structure, as 1H NMR is sensitive to changes in the envir-
onment of each hydrogen atom of a molecule. By searching the
REFOLD database28, we found that 34 of 1001 refolded proteins used
this NMR spectroscopy in some way. In the majority of cases, the
studies were driven by NMR, and the refolded protein was produced
and isotopically labeled for analysis. Only three proteins from the
database used simple 1D 1H NMR spectra, two of them for visual
inspection29,30, and one for comparison with the natural modified
protein31. In a recent study32, the authors compared the 1D 1H
NMR spectra from the refolded protein and the protein purified from
soluble fraction. They concluded that the structures were exactly the
same because the spectra were identical (no spectral difference was
presented). In a recent review33 focused on tools used to evaluate
protein conformations, NMR is briefly mentioned as one of the
leading techniques of structural biology. The authors said that
NMR ‘‘still requires very sophisticated equipment, appreciable
amounts of sample, and specialist human resources that keep them
away from the pipeline in protein production and control. Newer
techniques (or new applications of well-established techniques) are
being developed to complement these traditional biophysical assays
and to provide information on the success of protein folding.’’ We
want to stress that the proposed method uses the detailed informa-
tion present in NMR spectra in a simple way, to answer a simple
question. If NMR (as x-ray crystallography) is analyzed as a tool to
determine three-dimensional protein structure, then it presents the
difficulties pointed out in the aforementioned review; however, this is
not the case for the 1D 1H spectra needed for conformational com-
parisons of two samples.
Conclusion
One-dimensional homonuclear 1H NMR spectroscopy requires no
special sample production and little time for measurement.
Typically, a high quality spectrum of a 500 mL protein sample
(,100 mM of a small protein) on a 600 MHz spectrometer can be
obtained in less than 30 minutes. Most of the time is spent on adjust-
ment of the equipment and definition of experimental parameters.
Using spectrometers with a cryoprobe is desirable, but not required.
Spectra processing and comparison is very quick and can be per-
formed immediately after acquisition using spectrometer software.
Finally, simple precautions should be taken for the preparation of
NMR samples. TheNMRbuffer should be of neutral to acidic pH and
low ionic strength. High pH results in less protonated amides, caus-
ing loss of signal. Low salt concentration (up to 300 mM) is required
tominimize radiowave reflections duringNMRpulses that can cause
heating of the sample (tuning and matching of the spectrometer
probe head). 1H NMR is very sensitive to non-water exchangeable
hydrogens of small molecules, and, as a consequence, the use of
hydrogen-containing buffer agents (like Tris, Acetate, MES, and
HEPES) and some other molecules (glycerin, DTT, etc.) should be
avoided, or these reagents can be replaced by their deuterated equiva-
lents. Sodium or potassium phosphate buffer is recommended, since
the hydrogen atoms of these compounds are exchangeable with
water, resulting in a signal that is coincident with the water resonance
Figure 1 | (A) sP21-His6 and rP21-His6 affect invasion of Vero cells by T. cruzi TCT and EA. Light microscopy of (a) TCT invasion and (B) EA invasion
after treatment with (1) DMEM (control, not treated), (2) 40 mg/mL of rP21-His6 and (3) 40 mg/mL of sP21-His6. (4) Quantification. Arrows in (1), (2),
and (3) indicate internalized parasites. (C) Phagocytosis of zymosan particles by mice peritoneal macrophages in the presence of sP21-His6. Light
microscopy of (1) control (untreated) cells and (2) cells treatedwith 40 mg/mL sP21-His6. (3)Quantification of (1) and (2). Arrows in (1) and (2) indicate
internalized particles.
www.nature.com/scientificreports
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that should be suppressed. Moreover, extensive care with contami-
nants should be taken, as 1H NMR can detect contaminant signals,
even in small concentrations.
Methods
Protein expression and cell lysis. P21-His6 was expressed in Escherichia coli BL21
cells transformedwith a pET-28a(1) (Novagen) expression vector, which contains an
N-terminal His6-tag followed by a thrombin recognition site. Expression was carried
out in 8 L of 2xYT medium (16 g tryptone, 10 g yeast extract, 5 g NaCl per 1 L
medium) containing 35 mg/mL kanamycin. Bacteria were incubated at 37uC until the
optical density at 600 nm (OD600) reached ,0.7, at which point expression was
induced by addition of 0.5 mM isopropyl b-D-1-thiogalactopyranoside (IPTG).
Cultures were then incubated for an additional 3 hours at 37uC. Cells were harvested
by centrifugation at 6,000 3 g for 40 minutes at 4uC and resuspended in lysis buffer
(50 mM Tris, 300 mM NaCl, 20 mM imidazole, pH 8.0) containing 1 mg/mL
lysozyme. The solution was maintained on ice for 30 min before cells were lysed by
ultrasound (15 cycles of 40 s at 40 W, 40 s interval). The lysate solution was subjected
to centrifugation (14,000 3 g for 40 min at 4uC), and both supernatant and pellet
were used for native and denaturing purification of the protein, respectively.
Native P21-His6 purification from the soluble fraction (sP21-His6). The soluble
fraction was added to 2 mL of Ni-NTA resin (Qiagen) and extensively washed with
lysis buffer. To remove low-affinity bound proteins, a second wash with wash buffer
(50 mM Tris, 300 mM NaCl, 50 mM imidazole, pH 8.0) was performed. sP21-His6
was eluted with elution buffer I (50 mMTris, 300 mMNaCl, 160 mM imidazole, pH
8.0), concentrated, and dialyzed against buffer II (50 mMTris, 50 mMNaCl, pH 8.0).
Denaturing P21-His6 purification and refolding from the insoluble fraction
(rP21-His6). In order to extract the expressed protein from inclusion bodies, the
lysate pellet was resuspended in urea buffer (50 mM Tris, 300 mM NaCl, 5 mM
imidazole, 6 M urea, 5% (v/v) glycerol, pH 8.0) and stirred overnight at room
temperature. After centrifugation (14,000 3 g for 40 min at 4uC), the supernatant,
containing P21-His6 extracted from the inclusion bodies, was immobilized in a
column containing 5 mL Ni-NTA resin fixed on an A¨kta Purifier system. After
extensive washing with urea buffer, the urea concentration was slowly decreased with
a linear buffer gradient (27 mM/min of urea, 0.5 mL/min)23. To remove glycerol and
additional impurities, the columnwaswashedwithwash buffer until no protein signal
was detected. rP21-His6 was eluted with elution buffer II (50 mM Tris, 300 mM
NaCl, 220 mM imidazole, pH 8.0), concentrated, and dialyzed against buffer II (see
above).
Cell lines and cultures. Vero cells were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Cultilab),
10 mg/mL streptomycin (Sigma), 100 U/mL penicillin (Sigma), and 40 mg/mL
gentamycin (Sigma) at 37uC in a humidified atmosphere containing 5% CO2.
Peritoneal macrophages from BALB/C mice were harvested from the peritoneal
cavity in 5 mL DMEM.Mice were stimulated with 1 mL 3% thioglycollate medium 3
days prior to harvest.
Parasites. To generate tissue-cultured trypomastigotes (TCT) from the CL strain,
confluent monolayers of Vero cells were infected with metacyclic trypomastigotes
andmaintained for at least two weeks to establish the intracellular cycle. Extracellular
amastigotes (EA) were derived from trypomastigotes by axenic differentiation.
Infected Vero cell cultures were subjected to centrifugation (2500 3 g, 5 minutes),
and the pellet was resuspended in liver infusion tryptose (LIT) medium. Finally, the
resuspension was incubated for 18 hours at 37uC to generate at least 95% pure
extracellular amastigotes.
Animals and ethics. Male or female BALB/c mice were six to eight weeks old and
weremaintained under standard conditions on a 12 hour light, 12 hour dark cycle in a
temperature controlled room (25 6 2uC) with food and water ad libitum. All
experimental protocols were approved by the Ethics Committee from Universidade
Federal de Uberlaˆndia. Moreover, maintenance and care of these animals complied
with the guidelines of the Laboratory Animal Ethics Committee from the Institution.
Animal euthanasia was performed in accordance with international welfare grounds,
Figure 2 | (A) SDS-PAGE of bacterial lysate, showing the predominate expression of P21-His6 in the insoluble fraction. Lanes: (MW) molecular weight
markers, (BI) lysate before IPTG induction, (IF) insoluble fraction after induction, and (SF) soluble fraction after induction. Arrow indicates the position
of P21-His6. (B) Circular dichroism (CD) spectra of refolded and soluble P21-His6. Superposition of rP21-His6 (blue) and sP21-His6 (green) CD spectra
at 20uC. Refolded and soluble protein samples have similar secondary structure composition. (C) Comparison between 1D1HNMR spectra of sP21-His6
and rP21-His6, showing exactly the same structure for both proteins. Spectrum of refolded (blue) and soluble (red) protein; spectra difference after
normalization (green). The marked peaks indicate (c) low weight contaminants, (d) DSS, and (e) residual ethanol.
www.nature.com/scientificreports
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according to the American Veterinary Medical Association Guidelines on
Euthanasia.
Host cell invasion assay. A volume of 500 mL Vero cell suspension (1.5 3 105 cells)
was added to multiwell plates containing sterile glass coverslips and incubated
overnight. The invasion assay was performed by adding EA (20 parasites per cell) or
TCT (10 parasites per cell) to plates in the presence or absence of 40 mg/mL sP21-His6
or 40 mg/mL rP21-His6. The plates were incubated for 2 hours at 37uC in a humidified
incubator containing 5% CO2. After incubation, the cells were gently washed three
times with PBS, fixed with Bouin’s solution, and stained with Giemsa.
Phagocytosis assay. Zymosan particles (10 mg/mL, Sigma) were resuspended in
sterile PBS, sonicated for 15 minutes, and pelleted by centrifugation. To determine
particle concentration, a Neubauer chamber was used for counting. Resident
peritoneal macrophages were seeded in cell culture well plates (5 3 105 cells/well)
containing 13 mm round glass coverslips and were then incubated overnight in a
humidified atmosphere containing 5% CO2 at 37uC to allow the cells to adhere. Non-
adherent cells were removed by washing with PBS before adding DMEM containing
10% FBS. To perform the phagocytosis assay, zymosan particles were added to wells
(20 particles/each macrophage fixed) in the presence or absence of 40 mg/mL sP21-
His6. Particles were incubated with macrophages for 2 hours. The cells were then
washed with PBS, fixed in Bouin’s solution, and stained with Giemsa. Results were
expressed as the number of internalized particles/100 cells. These results were
compared to those previously determined for rP21-His6 using the same protocol22.
Circular dichroism spectropolarimetry (CD). Spectra were recorded on a Jasco 815
CD spectrometer using 0.1 cm thick quartz cells. Samples containing 0.15 mg/mL
sP21-His6 or rP21-His6 in 10 mM sodiumphosphate buffer (pH 7.4) were analyzed at
20uC to assess structural similarity.
Nuclear magnetic resonance spectroscopy (NMR). Samples of sP21-His6 and rP21-
His6 were concentrated to the same concentration (1.3 mg/mL, 70 mM in a final
volume of 500 mL) and then simultaneously dialyzed against 2 L NMR buffer
(50 mM potassium phosphate, 150 mM KCl, pH 6.0) at 4uC. The NMR buffer was
changed twice to ensure that the samples were in exactly the same buffer conditions
for NMR measurements, as 1H signals are very sensitive to changes in their
environment. DSS (100 mM, for spectrum referencing) and D2O (5% v/v), for tuning
and matching the spectrometer probe head) were added to both samples. 1D 1H
spectra were recorded at 303 K in a high-resolution, small bore 600 MHz Bruker
Avance III spectrometer. Since the spectrometer was equipped with a TCI cryoprobe,
a 43 enhancement in the signal intensity was achieved. The intense water signal
around 4.8 ppm, typical for an aqueous protein sample, was suppressed using a
standard watergate W5 pulse sequence. To ensure spectra with a good signal to noise
ratio were obtained for the diluted samples, each 1D experiment was acquired with a
total of 256 scans, resulting in an experimental time of approximately 17 minutes per
spectrum. Proton chemical shifts were referenced (0 ppm) to the 1H resonance
frequency of the sharp and intense signal of the methyl groups in DSS. Time-domain
data were acquired and processed with an exponential line broadening of 1 Hz using
the Bruker BioSpin spectrometer control software TopSpin 3.1. The same software
was used for the spectra analysis and for obtaining the difference spectrum.
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